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Dectin-1, the receptor for b-glucans, protects the
host against fungal infection; however, its role in in-
testinal immunity is incompletely understood. We
found that Dectin-1-deficient (Clec7a/) mice were
refractory to both dextran sodium sulfate (DSS)-
and CD45RBhighCD4+ T cell-induced colitis, and
that this resistance was associated with an increase
in regulatory T (Treg) cells. The proportion of lacto-
bacilli, especially Lactobacillus murinus, in the
commensal microflora was increased in Clec7a/
mouse colons, and accompanied by a decrease
in antimicrobial peptides induced by Dectin-1 sig-
naling. L. murinus colonization increased Treg cells
in the colon. Oral administration of laminarin, a
Dectin-1 antagonist, suppressed the development
of DSS-colitis, associated with an increase of
L. murinus and Treg cells. Human patients with in-
flammatory bowel disease were found to have a
decreased proportion of closely related Lactoba-
cillus species. These observations suggest that
Dectin-1 regulates the homeostasis of intestinal im-
munity by controlling Treg cell differentiation through
modification of microbiota.
INTRODUCTION
Dectin-1 (gene symbol Clec7a), a C-type lectin receptor (CLR)
expressed in dendritic cells (DCs) and macrophages (Mf), is
the receptor for b-1, 3-linked glucans (b-glucans) (Taylor et al.,
2002). b-glucans are one of the major cell wall components ofCell Hosfungi, and Dectin-1 plays an important role in the host defense
against fungal infection by mediating induction of reactive oxy-
gen species and various cytokine productions (Saijo et al.,
2007; Taylor et al., 2007).
The intestinal immune system has to deal with dual functions;
the system should be tolerant toward commensal microbiota or
food components, and at the same time the system should fight
against invading pathogens. Through innate immune receptors
for pathogen-associated molecular patterns (PAMPs), such as
CLRs and Toll-like receptors (TLRs), innate immune cells sense
bacterial, fungal, and viral pathogens and subsequently produce
cytokines to activate host defense mechanisms (Kawai and
Akira, 2011). Antimicrobial peptides (AMPs), small molecular-
weight proteins secreted by intestinal epithelial cells, Paneth
cells, and innate immune cells, are one such host defense
mechanism induced by PAMPs (Gallo and Hooper, 2012).
S100A family members, especially S100A8-S100A9 heterodimer
(calprotectin), are effective to suppress Staphylococcus (Corbin
et al., 2008), and RegIII family members specifically kill
Gram-positive bacteria (Cash et al., 2006; Lehotzky et al.,
2010), suggesting that each AMP has its own antimicrobial
spectrum. PAMP-induced cytokines also recruit neutrophils,
promote specific helper T cell differentiation, and enhance IgA
production to control intestinal microbiota (Macpherson and
Uhr, 2004). However, the mechanisms to induce intestinal toler-
ance against commensal bacteria or food components remain
largely unknown.
Specific intestinal commensal microbiota can influence the
host immune system. Segmented filamentous bacteria promote
experimental autoimmune encephalomyelitis and autoimmune
arthritis by inducing Th17 cell differentiation (Lee et al., 2011;
Wu et al., 2010). In contrast, a mixture of Clostridium species
can suppress colitis by enhancing regulatory T (Treg) cell devel-
opment (Atarashi et al., 2011). Because b-glucans are present in
foods such as mushrooms, yeasts, and seaweeds, Dectin-1 int & Microbe 18, 183–197, August 12, 2015 ª2015 Elsevier Inc. 183
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Figure 1. Clec7a–/– Mice Are Refractory to DSS-Colitis
(A and B) Expression of Clec7amRNA in immune cells fromWT and Clec7a/ splenocytes and colonic epithelial cells (A) and the expression of Clec7a and Tnfa
mRNA in the colon from naive or DSS-administrated mice (n = 3/group) (B) were determined by real-time RT-PCR.
(C) Expression of Dectin-1 on colonic DCs (CD11c+F4/80), neutrophils (Gr-1+CD45+), macrophages (CD11cF4/80+), and epithelial cells (7-AADCD45) was
determined by flow cytometry before and after DSS administration.
(D–F) WT and Clec7a/mice were administrated with 4% (D) or 2% (E and F) of DSS in drinking water, and survival rate (D and E) and disease activity index (F)
were evaluated daily (n = 6/group).
(G–J) On day 11 after 2%DSS treatment, mice were sacrificed and the histology analysis of the distal colon (H&E staining, 1003) (G andH), the gross pathology of
the colon (I), and colon length measurement (J) were performed.
(legend continued on next page)
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the intestine may also be involved in the regulation of intestinal
immunity and microbial balance in the intestine.
In this study, we have investigated the role of Dectin-1 in the
regulation of the intestinal immunity. We found that Clec7a/
mice are refractory against twomousemodels for human inflam-
matory bowel diseases (IBDs). In these mice, one lactobacillus
species, which can induce Treg differentiation, was expanded
accompanied by a decrease of several AMP levels in the colon.
Furthermore, we showed that an antagonist of Dectin-1 from
seaweeds suppressed the development of DSS-colitis by
increasing the lactobacillus population and Treg cells in the
colon, providing insight into a homeostatic mechanism of the in-
testinal immunity.
RESULTS
Clec7a–/– Mice Are Resistant to Dextran SodiumSulfate-
Induced Colitis
Dectin-1 was expressed in myeloid cells such as DCs and Mf
(Figure 1A), and its expression in the colon was markedly upre-
gulated together with the expression of TNF after administration
of 2% DSS in drinking water (Figure 1B). In the colon of normal
mice, Dectin-1 was exclusively expressed on CD11c+F4/80
DCs in colonic lamina propria (cLP) (Figure 1C); in inflammatory
colon, CD11cF4/80+ Mf and Gr-1intCD11cintF4/80intMHCII
newly recruited/expanded inflammatory monocytes also ex-
pressed Dectin-1 (Figure 1C and see Figure S1B available
online), and most of the Dectn-1+ population was Mf (Fig-
ure S1C). Colonic epithelial cells did not express Dectin-1 (Fig-
ures 1A and 1C), even after DSS or TLR/CLR ligand treatment
(Figures 1C and S1A).
Clec7a/ mice were resistant to 2% or 4% DSS-colitis
compared to wild-type (WT) mice (Figures 1D and 1E). Colitis
severity scores were significantly lower in Clec7a/ mice (Fig-
ure 1F), and colonic epithelial cell damage and inflammatory
cell infiltration were much milder (Figures 1G and 1H). Inflamma-
tory edema-induced shortening of the colon was mitigated (Fig-
ures 1I and 1J), and infiltration of innate immune cells in cLP was
significantly reduced (Figures 1K, S1D, and S1E). Proinflamma-
tory cytokines such as TNF and IL-12 produced by cLP cells
were decreased (Figures 1L and S1F), while frequencies of
colonic Th1 and Th17 cells were not changed (Figure S1G).
IL-1a and IL-23were not detected in our assay conditions. These
observations show that Dectin-1 deficiency can suppress the
development of DSS-colitis.
Microbiota from the Clec7a–/– Mouse Intestine
Suppresses the Development of DSS-Colitis
The development of DSS-colitis is affected by intestinal micro-
biota (Tlaskalova´-Hogenova´ et al., 2005). We found that the
development of colitis was significantly suppressed in germ-
free (GF) mice upon treatment with 1% or 2% DSS compared
with SPF mice, and under GF conditions the severity of colitis
was similar between WT and Clec7a/ mice, suggesting that(K and L) Neutrophil number in cLP was measured by FACS (K), and cyt
stimulation (L).
Mice used in (A)–(L) are on C57BL/6 background. Four to six mice were used in
periments. Data in (A), (B), (F), (H), and (J)–(L) are expressed as means ± SD. *p
Cell Hosintestinal microbiota is involved in the development of colitis
(Figures 2A and 2B). To confirm the involvement of intestinal
microbiota in DSS-colitis, we first analyzed the development of
colitis in GF WT mice after transferring Peyer’s patch (PP) ho-
mogenates, which contain intestinal microbes captured by
DCs (Obata et al., 2010). We found that DSS-administrated
mice that received microbiota from SPF Clec7a/ mice devel-
oped significantly milder colitis; colon length shortening and
proinflammatory cytokine production were much mitigated
compared with WT microbiota-received mice (Figures 2C and
2D). Fecal microbiota from Clec7a/ mice could also give the
resistance to colitis (Figures 2E–2H and S2A–2C), whereas
microbiota from WT mice induced severe colitis even in GF
Clec7a/mice (Figures S2A–2C), suggesting that alteredmicro-
flora in SPFClec7a/mice, but not the lack of Dectin-1 in recip-
ient GF mice, is responsible for the increased resistance against
colitis.
We then compared intestinal microflora between WT and
Clec7a/ mice by analyzing 16S bacterial ribosomal DNA se-
quences from PPs and feces preparations. Althoughmajor phyla
of commensal bacteria were similar between Clec7a/ and WT
microflora, with approximately 80% Firmicutes, 10% Bacteroi-
detes, 23% Proteobacteria, and others (Figure 2I), the ratio of
Gram-negative to Gram-positive bacteria was nearly two times
less in Clec7a/ mice than that in WT mice (Figure S2D).
Notably, the proportion of lactobacilli in both fecal and PPs’
microflora ofClec7a/micewasmarkedly increased (Figure 2J),
while the frequency of clostridia was similar between Clec7a/
mice and WT mice (Figure S2E). Total amounts of 16S bacterial
rDNA in WT and Clec7a/ mouse feces were similar, but the
proportion of lactobacillus was four to five times higher in
Clec7a/ mice than that in WT mice (Figure S2F). Furthermore,
we identified Lactobacillus murinus (L. murinus) NBRC 14221 as
the major strain in fecal microflora of Clec7a/ mice, with over
ten timesmore than the strain inWTmicroflora (Figure 2K). These
observations suggested that the population of lactobacilli is
controlled by Dectin-1 and may influence the susceptibility to
DSS-colitis.
L. murinus Colonization Inhibits the Development of
DSS-Colitis
Then, we examined the potential role of L. murinus in the devel-
opment of DSS-colitis. When we monocolonized GF mice with
L. murinus (NBRC 14221) or Alcaligenes faecalis (A. faecalis), a
typical mouse commensal microbiota in the colon, we found
that these ex-GF mice monocolonized with L. murinus devel-
oped significantly milder colitis than GF or A. faecalis-colonized
mice (Figures S3A–S3D). Oral pretreatment of mice with heat-
killed L. murinus could also suppress the symptoms of DSS-
colitis (Figures S3E and S3F).
Next, we examined the effect of L. murinus overcolonization
on DSS-colitis in the presence of other commensal microbiota.
GF mice were monocolonized with L. murinus for 2 weeks, fol-
lowed by SPF WT microflora transfer into these ex-GF mice.okine levels were determined with ELISA in cultures after 48 hr without
a group in (G)–(L). Data in (D)–(L) are representative of three independent ex-
< 0.05, **p < 0.01, ***p < 0.001. See also Figure S1.
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Figure 2. Microbiota from the Clec7a–/– Mouse Intestine Suppresses DSS-Colitis
(A and B) SPF or GF WT and Clec7a/ mice were treated with 1% (A) or 2% (B) DSS, and body weight was measured every day (n = 5–6/group).
(C and D) At 3 days after oral transfer of Peyer’s patch homogenate fromSPFWT orClec7a/mice, recipient ex-GFmice were induced colitis with 1%DSS. After
11 days, colon lengths were measured (C), and Tnfa and Il12p35 mRNA in the colon were determined by real-time RT-PCR (D) (n = 5/group).
(legend continued on next page)
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Then these mice were administrated with 2% DSS for 5 days.
As shown in Figures 3A and 3B, ex-GF mice monocolonized
with L. murinus were less susceptible to DSS even after
SPF microflora transfer; the body weight of these mice
recovered much more quickly, and diarrhea and hematoche-
zia were also significantly milder in L. murinus-premonocolon-
ized group than those without L. murinus precolonization.
Colonic inflammation was also significantly alleviated (Figures
3C–3F). However, when SPF mice were administrated with
L. murinus 14 days before treatment with DSS, we did not
find any effect of L. murinus on colitis (Figures S3G–S3J).
This is because transferred L. murinus could not efficiently
colonize in SPF mouse colon (Figure S3K). In contrast,
L. murinus efficiently colonized in GF mice (Figure S3L), prob-
ably due to the absence of competing commensal bacteria.
These observations suggest that L. murinus overcolonization
is one of the reasons for the resistance to DSS-colitis in
Clec7a/ mice.
When fecal microflora from SPF WT mice was transferred to
GF mice, L. murinus population expanded quickly in Clec7a/
recipients, but not in WT recipients, and the population
expanded 7 times after 3 weeks and 21 times after 4 weeks (Fig-
ure 3G). These results clearly indicated that L. murinus popula-
tion is tightly controlled by Dectin-1 signaling.
Commensal fungi are reported in mammalian intestine (Ott
et al., 2008; Scupham et al., 2006), and a recent study by
Iliev et al. showed that DSS treatment allows pathogenic
fungi to invade the intestinal wall and that Dectin-1 plays an
important role in protecting the host from ‘‘fungus-aggravated’’
colitis (Iliev et al., 2012). In our SPF mouse colony, however, we
could not detect any viable fungi in feces (Figure 3H, <1 CFU/
fecal pellet) and intestinal mucosa (0 CFU in colonic lavage
fluid). Although we detected the internal transcribed spacer re-
gion (ITS 1–2) of fungal rDNA in feces of SPF mice by qPCR,
this rDNA could also be detected in GF mouse feces with
similar levels (Figures S3M and S3N), suggesting that this
DNA was derived from fungal DNAs contaminated in food or
bedding.
We also tested the effect of colonization of C. tropicalis, the
major pathogenic fungus found in Iliev’s mouse colony (Iliev
et al., 2012), on DSS-colitis. Although C. tropicalis cells were
detected in the intestinal tract after colonization using immuno-
histochemical methods, no such fungal cells were detected
in uncolonized SPF mice (Figure 3I). C. tropicalis-colonized
Clec7a/ mice did develop much severe colitis compared
with uncolonized Clec7a/ mice or colonized WT mice (Fig-
ures 3J, 3K, S3O, and S3P), consistent with the results ob-
tained by Iliev et al. (Iliev et al., 2012). These results indicate
that Dectin-1 deficiency does aggravate DSS-colitis when
mice are colonized with pathogenic fungi, whereas the same(E–H) SPFWT or Clec7a/mouse feces were orally administrated to GFWTmic
disease index (F) were examined every day. On day 7 after DSS-treatment, ex-G
(n = 5/group).
(I–K) Proportions of major commensal bacteria phyla in feces (I), relative abunda
major Lactobacillus species in fecalmicroflora (K) fromSPFWT andClec7a/mic
to the amount of total bacterial DNA (n = 3/group).
Mice used in (A)–(K) are on C57BL/6 background. Data in (A)–(K) are representative
as means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S2 and Table
Cell Hosdefect ameliorates colitis when mice are free from fungal
colonization.
L. murinus Induces Treg Expansion/Differentiation in
Clec7a–/– Mouse Intestines
We next investigated the mechanism by which L. murinus pro-
vides DSS-colitis resistance in Clec7a/ mice. We found that
CD4+ T cells expressing Foxp3, the signature transcription factor
for Treg cells (Hori et al., 2003), significantly expanded in cLP
lymphocytes (cLPLs) in Clec7a/ mice compared with those
cells in WT mice (Figure 4A). The expansion was observed not
only in DSS-treated mice but also in untreated mice (Figure 4A).
When GFWTmice were colonized with L. murinus or A. faecalis,
Foxp3+CD4+ or IL-10-producing CD4+ T cell populations in
cLPLs were significantly increased in L. murinus-colonized, but
not A. faecalis-colonized, mice (Figures 4B–4E and S4A). IL-
17-producing, but not IFN-g-producing, cells also significantly
expanded by L. murinus colonization (Figure 4D). IL-10 and IL-
17 overproduction by T cells from L. murinus-colonized mice
were also confirmed ex vivo (Figure 4E). Because over 90% of
cLP IL-10-producing CD4+ T cells were Foxp3+, most IL-
10+CD4+ T cells are considered to be Treg cells (data not shown).
Similar expansion of Treg cells in L. murinus-colonized mice was
also observed even in the presence of commensal microbiota of
SPF mice; frequencies of cLP CD25+Foxp3+ Treg cells and IL-
10-producing CD4+ T cells were significantly higher in ex-GF
L. murinus-colonized mice than those in control mice, both of
which were transferred with SPF microbiota 1 day before DSS
administration (Figure 4F). These observations suggest that
L. murinus can promote differentiation of Treg cells and IL-17-
producing Th17 cells in the colon.
Because Treg cells are important to regulate inflammatory
responses in the intestine (Atarashi et al., 2011; Barnes and
Powrie, 2009; Coombes et al., 2005), Treg cell expansion
in Clec7a/ mice may explain the resistance to DSS-colitis
in these mice. Actually, we found that, in contrast to
Clec7a/ mice, Rag2/Clec7a/ mice in which Treg cells
were absent were susceptible to colitis, supporting the notion
that these Treg cells are important for the suppression of
colitis (Figures S4B and S4C). However, compared to Rag2/
mice, the disease index of Rag2/Clec7a/ mice was
lower at day 6 and 7 after DSS treatment (Figure S4D).
L. murinus population expanded in Rag2/Clec7a/ mice
as in Clec7a/ mice (Figure S4E). These results suggest that
L. murinus-induced Treg cell expansion in the colon mainly pro-
vides resistance against DSS-colitis, although involvement of
Treg-independent suppression mechanism is also suggested
in some part.
We also examined the effect of Dectin-1 deficiency in another
colitis model. When WT CD25CD45RBhighCD4+ T cells weree. After 3 days, they were administrated with 2% DSS, and body weight (E) and
F mouse colons were examined histologically (H&E staining, 1003) (G and H)
nce of total Lactobacillus genus in feces or PPs (J), and relative abundance of
e were determined by sequence analysis of bacterial 16S rDNA and normalized
of two independent experiments. Data in (A)–(C), (E), (F), and (H) are expressed
S1.
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Figure 3. Overcolonization of L. murinus Population Is Responsible for the Resistance to DSS-Colitis in Clec7a–/– Mice
(A–F) GF WT mice were colonized with L. murinus. Thirteen days later, these mice were administrated with SPF WT mouse fecal microflora and treated with 2%
DSS the next day. Five days after DSS treatment, mice were refed with normal water. Body weight (A) and disease index (B) were inspected every day. On day 12
after the first DSS treatment, gross pathology (C), colon length measurement (D), and histological analysis of the colon (H&E staining, 1003) (E and F) were
performed (n = 4/group).
(legend continued on next page)
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transferred into Rag2/ or Rag2/Clec7a/ mice, body
weight loss in Rag2/Clec7a/ mice was significantly miti-
gated, with milder colonic shortening and cecal/colonic inflam-
mation compared with Rag/ mice (Figures 4G and 4H and
S4F–S4H). CLP Treg cells expanded more efficiently in
Rag2/Clec7a/ mice than in Rag2/ mice (Figure 4I). Upre-
gulation of Foxp3 expression and Th17 differentiation was also
observed in the colon of Rag2/Clec7a/ mice (Figures 4J
and 4K). Although protective as well as inflammatory roles of
IL-17A and IL-17F were suggested in the development of colitis
(Ahern et al., 2010; Hueber et al., 2012; O’Connor et al., 2009),
we did not detect any effect of IL-17A/F deficiency on the
development of DSS colitis under our experimental conditions
(Figures S4I–S4K). These observations suggest that Treg cell
expansion caused by L. murinus is important for the colitis resis-
tance in Clec7a/ mice.
L. murinus Induces TGF-b and IL-10 Expression in
Colonic DCs and Mf to Promote Treg Cell
Differentiation
Then, we analyzed the mechanism of Treg cell differentiation by
L.murinus.We found that the expression of TGF-b, which plays a
crucial role in Treg differentiation by inducing Foxp3 expression
in naive T cells (Chen et al., 2003), was significantly higher in
Clec7a/mouse colons as well as in Rag2/Clec7a/mouse
colons (Figures 4J and 5A). The expression of gene-encoding
RORgt, the signature transcription factor for Th17 cells (Ivanov
et al., 2006), but not T-bet, a Th1-specific transcription factor,
was also significantly upregulated in Clec7a/ mouse colon
(Figures 5B and 5C). We then found that the expression of
Tgfb as well as Il10 mRNA in antigen-presenting cells (APCs)
such as DCs and Mf purified from cLP was drastically upregu-
lated by L. murinus stimulation, but not by A. faecalis or Escher-
ichia coli (E. coli) K12 stimulation (Figure 5D). None of these
commensal bacteria upregulated Tnf, Il6, or Il1b expression in
colonic APCs, making a clear contrast to splenic APCs in which
these proinflammatory cytokines were markedly induced (Fig-
ures S5A and S5B). When whole cLP cells were cocultured
with these commensal bacteria, only L. murinus, but not
A. faecalis or E. coli, induced Foxp3 and Rorc, but not Tbx21,
expression (Figure 5E), consistent with the expansion of Treg
and Th17 cells, but not Th1 cells, after in vivo L. murinus-
colonization (Figures 4B–4D). These observations suggest that
commensal L. murinus specifically induces TGF-b and IL-10 in
cLP APCs, which subsequently promote Treg cell differentiation.
Because Clec7a/ cLP cells similarly induced Tgfb mRNA as
WT cells after L. murinus stimulation, this TGF-b induction by(G) Fecal microflora from SPF C57BL/6WTmice were orally transferred into GFW
qPCR at the indicated time after transfer. Data show fold changes normalized to
(H) Fungal colonies were determined using fecal pellet lysate. As controls, know
specific medium plates in the presence of mouse fecal lysate.
(I) Fungi in mouse intestinal tract were immunohistochemically detected using inse
blue stained, DAPI).
(J and K) WT or Clec7a/ mice were orally colonized with C. tropicalis on days 0
were administrated with 2% DSS. Loss of body weight (J) and survival (K) were
colonized WT control, *p < 0.05; uncolonized Clec7a/ versus uncolonized WT
Mice used in (A)–(J) are on C57BL/6 background. All data are representative of two
means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S3.
Cell HosL. murinus was independent of Dectin-1 activity (Figures S5C
and S5D).
Dectin-1 Signaling Induces AMPs that Suppress
Lactobacillus Growth
Next, we explored the reason why L. murinus population
expanded in Clec7a/ mice. We found that the expression of
a group of AMPs, such as S100A8 in the colon of Clec7a/
mice, or S100A8, RegIIIb, RegIIIg, and phospholipase A2 in
Rag2/Clec7a/ mice was specifically reduced compared
with that of control mice (Figures 5F, 5G, S6A, and S6B).
RegIIIb and RegIIIg expression in purified epithelial cells from
Rag2/Clec7a/ mouse colon was also significantly impaired
(Figure S6C). Dectin-1 ligand stimulation significantly upregu-
lated the expression of these AMPs in cultured mouse colon
pieces (Figures 5H and S6D), suggesting that these AMPs
were induced by Dectin-1 signaling.
We then examined whether AMPs show any microbial spe-
cies-specific effects. When L. murinus and A. faecalis were
cultured with recombinant S100A8+S100A9 peptides for 9 hr,
only L. murinus growth, but not A. faecalis growth, was sup-
pressed (Figure 5I). These results suggest that Dectin-1 signaling
controls the population of L. murinus, probably by inducing
several AMPs that suppress lactobacillus growth. S100A8 was
not induced by overcolonized L. murinus, because S100a8 levels
were similar between WT and Clec7a/microflora-received ex-
GF WT mice, in the latter of which L. murinus population was
significantly expanded (Figures S6E and S6F).
Laminarin, a Dectin-1 Antagonist, Can Suppress the
Development of DSS-Colitis
Then we examined the effect of Dectin-1 inhibition on the devel-
opment of DSS-colitis. Laminarin, amixture of short-chain b-glu-
cans from seaweeds, competitively inhibits agonistic b-glucan
binding to Dectin-1 (Huang et al., 2012; Maneu et al., 2011) (Fig-
ure 6A). Continuous administration of laminarin in food for 3 days
before treatment with DSS prevented the weight loss and miti-
gated the severity of colitis compared with the control groups
(Figures 6B–6D). Neutrophil and inflammatory CD103-DC infiltra-
tion and TNF production in cLP were significantly suppressed in
laminarin-treated mice (Figures 6E and 6F). Instead, IL-10
production was significantly increased (Figure 6F), and CD25+
Foxp3+ Treg cell population was drastically expanded (Figures
6G and 6H). On day 9 after laminarin administration, L. murinus
proportion in feces was significantly increased compared with
the control group (Figure 6I). These findings suggest that
Dectin-1 antagonists in food can suppress the development ofT or Clec7a/mice, and relative content of L. murinus rDNA was measured by
total 16S rDNA versus WT control.
n numbers of C. tropicalis were detected after cultivation for 48 hr on fungal-
ct-derived b-glucan binding protein (red stained, PE-b-glucan binding protein;
, 2, 4, and 8 four times, and from day 6 fungus-colonized or uncolonized mice
inspected every day (n = 5/group). C. tropicalis-colonized Clec7a/ versus
control, *p < 0.05, **p < 0.01.
independent experiments. Data in (A), (B), (D), (F), (G), and (J) are expressed as
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Figure 4. Treg Cells Are Expanded in Clec7a–/– Mice and L. murinus-Colonized Mice
(A) Frequencies of Foxp3+CD4+ T cells in cLP lymphocytes (cLPLs) from control or DSS-administrated mice were evaluated by FACS. Each symbol represents an
individual mouse.
(B–E) GF ICR WT mice were monocolonized with 106 CFU of L. murinus for 5 weeks, and proportions of CD25+Foxp3+CD4+ T cells (B) and IL-10+, IL-17+, and
IFN-g+ CD4+ T cells (C and D) in cLPLs were examined by FACS. Colonic LPLs were further stimulated with anti-CD3 mAb for 48 hr, and IL-10 and IL-17
concentration in culture supernatant was determined by ELISA (n = 5/group) (E).
(F) GFWTmice were colonized with L. murinus. Thirteen days later, these mice were administrated with SPFWTmouse fecal flora and then treated with 2%DSS
next day for 5 days. On day 12 after the first DSS treatment, mice were sacrificed and proportion of cLP Treg and IL-10-producing T cells was determined by
FACS (n = 4/group).
(legend continued on next page)
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colitis by inducing Treg cell expansion via facilitating L. murinus
growth in the intestine. Although laminarin suppressed AMP
expression in GF mice, Foxp3 upregulation was not observed
in these mouse colons (Figures S7A and S7B). Laminarin did
not suppress the development of DSS-colitis in GFmice (Figures
S7C and S7D), consistent with the notion that commensal mi-
crobiota is responsible for the induction of Treg cells and the
suppression of DSS-colitis. Laminarin also did not suppress
the development of colitis in Clec7a/ mice, indicating that
the protective effect of laminarin is mediated through blockade
of Dectin-1 (Figures S7E–S7H).
Lactobacillus Species Closely Related to L. murinus Is
Reduced in Human Feces with IBD
We next investigated the presence of L. murinus or related
species in human feces. We found that L. murinus was rarely
detected in human feces (Figure 7A; <0.00001% of total bacte-
ria). However, L. salivarius, a closely related lactobacillus
(94.2% 16S rDNA homology), was detected in both mouse
and human feces (Figure 7A; 0.006% of total bacteria). In pa-
tients with Crohn’s disease (CD) or ulcerative colitis (UC), the
percentage of L. salivarius in CD patients was significantly
decreased, although the proportion of total lactobacillus in
fecal microflora was increased compared with healthy volun-
teers (Figure 7B).
Next, we investigated Tgfb- and Il10-inducing activity of these
lactobacilli. L. murinus was most efficient to induce Foxp3
expression, associated with high Tgfb- and Il10-inducing activ-
ity; L. salivarius also significantly induced Tgfb and Il10 in colonic
APCs (Figure 7C), consistent with previous reports (Castellazzi
et al., 2007; O’Mahony et al., 2006). However, neither
L. animalis (KCTC 3501 strain, NBRC 15882), which was de-
tected in mouse but not human feces (Figure 7A) and has
99.7% homology with L. murinus, nor L. johnsonii and
L. reuteri, which also expanded in Clec7a/ mouse intestine
(Figure 2K), upregulate the expression of TGF-b and IL-10 signif-
icantly (Figure 7C). These observations suggest that some
L. murinus-related lactobacilli, such as L. salivarius, may also
be involved in the protection against intestinal inflammation in
humans.
DISCUSSION
In this report, we have shown that Clec7a/mice are refractory
against both DSS-induced and CD25CD45RBhiCD4+-T cell-
induced colitis due to the expansion of Treg cells in the intestine.
We found that the L. murinus population in colonic microbiota
was significantly increased in Clec7a/ mice compared with
WT mice, accompanied by a decrease of the expression of a
group of AMPs, such as S100A8 and RegIIIg, which were
induced by Dectin-1 signaling. Importantly, all these AMPs
commonly target Gram-positive bacteria (Gallo and Hooper,(G–K) CD25CD45RBhighCD4+ naive T cells were transferred intoRag2/ orRag2
Rag2/ group, n = 12 in Rag2/Clec7a/ group). On day 36 after the transfer,
TgfbmRNA (J), and IL-17+ CD4+ and IFN-g+ CD4+ cells (K) were determined by FA
Mice used in (A) and (F) are on C57BL/6 background, and in (G)–(K) are on B
experiments, and data in (G)–(K) are representative of three independent experim
0.01. L. m-N.B., L. murinus-gnotobiotic. L. m-colo., L. murinus-colonized. See a
Cell Hos2012), and the expansion of Gram-positive bacteria, including
lactobacilli, was observed in Clec7a/ mouse colon. In partic-
ular, we identified S100A8-9 as a potent suppressor against
L. murinus growth.
We showed that L. murinus colonization can promote Treg
expansion, and these L. murinus-colonized mice are more resis-
tant against DSS-colitis. Treg differentiation was also enhanced
in Rag2/Clec7a/ mice adoptively transferred with naive
T cells, in which L. murinus also overexpanded. L. murinus was
suggested to induce Treg cells, because L. murinus directly
stimulates cLP-resident DCs and Mf to produce TGF-b and
IL-10, which are important for normal Treg function (Chaudhry
et al., 2011) and sustainment of Foxp3 expression (Murai et al.,
2009) to promote Treg differentiation. Consistent with our obser-
vation, it was reported that some lactobacillus species can
induce Treg differentiation in vitro and suppress the develop-
ment of dermatitis and asthma (Jang et al., 2012; Shah et al.,
2012).
The involvement of Treg cells in the suppression of DSS-
colitis was supported by the observation that the resistance
against DSS-colitis in Clec7a/ mice was mostly canceled in
Rag2/-background mice. However, we do not exclude the
possibilities completely that other Rag2-dependent cells such
as regulatory B cells (Yang et al., 2013), or regulatory Foxp3+
invariant NKT cells (Monteiro et al., 2010), or Th17 cells (O’Con-
nor et al., 2009) are also involved in this suppression. In addition,
because the disease index was mitigated in Rag2/Clec7a/
mice compared with Rag2/mice in the early phase of the dis-
ease, Dectin-1-mediated innate immune mechanisms are also
suggested to be involved in the development of colitis. Probably,
Dectin-1-induced proinflammatory cytokines, such as TNF and
IL-1, may directly participate in the development of colitis, or
regulatory cytokines such as TGF-b and IL-10, which are
induced by expanded L. murinus in Rag2/Clec7a/ mice,
directly suppress immune responses.
We showed that laminarin acts as a Dectin-1 antagonist, and
preadministration with laminarin suppressed the development
of DSS-colitis, associated with the proinflammatory cytokine
reduction, L. murinus overgrowth, and Treg cell expansion
in the colon. All these effects of laminarin were similar to those
found in Clec7a/ mice. These observations indicate that
food-derived antagonistic b-glucans can attenuate Dectin-1
signaling, causing expansion of Treg population by enhancing
lactobacillus growth.
In contrast to our study, a recent study by Iliev et al. showed
that Clec7a/ mice are more sensitive against DSS-colitis
because of the expansion of pathogenic commensal fungi in
the gut (Iliev et al., 2012). However, we could not detect any
live fungi in the feces of our SPF mice. Interestingly, when these
SPFmicewere colonizedwithC. tropicalis, themajor pathogenic
fungus found in mouse intestine (Iliev et al., 2012), Clec7a/
mice became more susceptible to DSS-colitis than WT mice,/Clec7a/mice, and body weight was inspected every 3–4 days (G) (n = 7 in
colon length (H), colonic Foxp3+ Treg cell number (I), expression of Foxp3 and
CS or qPCR (in I–K, n = 6 in Rag2/ group, n = 4 in Rag2/Clec7a/ group).
ALB/c background. Data in (A)–(F) are representatives of two independent
ents. Data in (E), (G), (H), and (J) are expressed as means ± SD. *p < 0.05, **p <
lso Figure S4.
t & Microbe 18, 183–197, August 12, 2015 ª2015 Elsevier Inc. 191
D0
10
20
30
40
50
Non. L.murinus A.facaelis E.coli
Tgfb
0
10
20
30
40
50
Il10 Il1b
m
R
N
A 
re
la
tiv
e 
ex
pr
es
si
on
0
0.002
0.004
0.006
0.008
0.010
0.012
0.014** **
Non. L.murinus A.facaelis E.coli Non. L.murinus A.facaelis E.coli
E
Foxp3
m
R
N
A 
re
la
tiv
e 
ex
pr
es
si
on
0
0.4
0.8
1.2
1.6
2.0
*
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
0
1
2
3
4
5
6
7
**
Rorc Tbx21
Non. L.murinus A.facaelis E.coli Non. L.murinus A.facaelis E.coli Non. L.murinus A.facaelis E.coli
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
S100a8 S100a9
*
R
el
at
iv
e 
ex
pr
es
si
on
F
0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
0 5 10
**
S100A8/S100A9
Non-additive
0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
0 5 10
I
La
ct
ob
ac
ill
us
m
ur
in
us
[O
D
60
0]
A
lc
al
ig
en
es
fa
ec
al
is
[O
D
60
0]
Hours after antimicrobial peptides addition
H
S100a8
No-stimu.
Dep-Zymo.
m
R
N
A 
re
la
tiv
e 
ex
pr
es
si
on
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
mouse2mouse1
WT
Clec7a-/-
S100a8
0
0.2
0.4
0.6
0.8
1.0
1.2 *
Rag2-/- Rag2-/-
Clec7a-/-
m
R
N
A 
re
la
tiv
e 
ex
pr
es
si
on
G
B
R
el
at
iv
e 
ex
pr
es
si
on
Tbx21 Rorc
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
**
WT
Clec7a-/-
A
Tbx21 Rorc
0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6 **
R
el
at
iv
e 
ex
pr
es
si
on
Rag2-/-
Rag2-/-Clec7a-/-
0
1
2
3
4
5
6
7
Rag2-/- Rag2-/-
Clec7a-/-
*
0
1
2
3
4
5
6
WT Clec7a-/-
*
R
el
at
iv
e 
ex
pr
es
si
on
Tgfb Tgfb
C
Figure 5. Dectin-1-Induced AMPs Specifically Inhibit the Growth of L. murinus, which Can Induce TGF-b and IL-10 in Colonic APCs
(A–C) The expression of the mRNA encoding TGF-b (A), T-bet, and RORgt (B) (C) in the colon of indicated naive mice was determined by real-time RT-PCR
(n = 4/group).
(D and E) 43 104 CD11b+ and CD11c+ cells purified fromWT cLP cells with an AutoMacs (D), or wholeWT cLP cells (E) were cocultured with 43 105 CFU/well of
L. murinus, A. faecalis, or E. coli for 12 hr. The expression of cytokines (D) and Treg, Th17, and Th1-specific transcription factors (E) was determined by real-time
RT-PCR.
(F and G) The expression of S100A family members in the colon from indicated untreated mice was determined by real-time RT-PCR (n = 4/group).
(legend continued on next page)
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as reported by Iliev et al. Thus, the sensitivity to DSS-colitis
changes depending on the presence of pathogenic fungi in the
intestine.
Our data suggest that Dectin-1 is constitutively activated by
the ligands in the intestine and suppresses Treg differentiation.
Thus, inhibition of Dectin-1 may be fundamentally beneficial for
the host under healthy conditions; it suppresses inflammation
caused by irritants, allergens, or infections by increasing Treg
cells. However, at the same time, excessive Dectin-1 inhibition
may cause the host to be susceptible to fungal infection in
the intestine, resulting in the aggravation of colitis. Excessive
Dectin-1 activation through b-glucans in foods or fungi may
also aggravate colitis by suppressing development of Treg cells
even in fungus-infected individuals. Thus, our observations sug-
gest the importance of the balance between agonistic and
antagonistic ligands for Dectin-1 for the homeostasis of the in-
testinal immunity.
Regarding the source of the Dectin-1 ligands, we first thought
that intestinal microbiota might express b-glucans. However, we
could not detect any Dectin-1 ligand expression in the colonic
microbiota. Therefore, it seemed likely that Dectin-1 is stimu-
lated by b-glucans in foods. Actually, we showed that curdlan
administrated as a food component aggravates DSS-colitis
and laminarin ameliorates the disease (Figure S7I), and we also
found that b-glucan-free food feeding alleviates the inflammation
in WT mice to a certain extent (Figures S7J and S7K). Because
vimentin was recently reported to be an endogenous Dectin-1
ligand (Thiagarajan et al., 2013), it is possible that Dectin-1 is
also stimulated by endogenous ligands other than b-glucans
from foods.
Because L. salivarius was detected in human feces and could
induce both TGF-b and IL-10 expression in colonic immune
cells, a similar regulation is suggested in humans. Actually, we
showed that the proportion of L. salivarius was reduced in intes-
tinal flora of IBD patients, suggesting a protective role of this
commensal species. In this context, it was reported that Dec-
tin-1 expression is upregulated in IBD patients (de Vries et al.,
2009), and fecal calprotectin is one good marker of IBD (Foell
et al., 2009). On the other hand, two single-nucleotide polymor-
phisms in CLEC7A are associated with medically refractory UC,
in which fungal infection may play a pathogenic role (Iliev et al.,
2012). Thus, the role of Dectin-1 in the pathogenesis of colitis
is complex, depending on the commensal microflora in the intes-
tine. Our observations provide insight into the roles of Dectin-1 in
the homeostasis of intestinal immunity andmay provide a clue to
prevent intestinal inflammation.
EXPERIMENTAL PROCEDURES
Mice
Clec7a/ mice (Saijo et al., 2007) were used after backcrossing for
nine generations to C57BL/6J mice or ten generations to BALB/cA mice.(H) Fresh colon sections from two Rag2/ mice were stimulated with depleted
RT-PCR.
(I) L. murinus or A. faecaliswas cultured in the presence of recombinant S100A8+S
measured with a spectrophotometer.
Mice used in (A)–(H) are on C57BL/6 background. Data in (A), (D)–(G), and (I) ar
sentative of two independent experiments. Data in (A)–(G)are expressed as mea
Cell HosBALB/cA-Rag2/ mice were kindly provided by Dr. Yoichi Shinkai, Kyoto
University. C57BL/6J or BALB/cA (CLEA Japan) control mice were bred
in the same facility, and age- and sex-matched WT mice were first
cohoused with genetically modified mice just after weaning at 3 weeks
old for at least 4 weeks, and then were separated for another 4–5 weeks
before use. All mice were kept under specific pathogen-free conditions
with g-ray sterilized normal diet (F1, Funahashi Farm, Chiba), acidified
(0.002 N HCl, pH 2.5) tap water, and autoclaved wooden chip bed in envi-
ronmentally controlled clean rooms at the Center for Experimental Medicine
and Systems Biology, Institute of Medical Science, University of Tokyo, and
at the Research Institute for Biomedical Sciences, Tokyo University of Sci-
ence. The experiments were carried out according to the institutional
ethical guidelines for animal experiments and the safety guidelines for
gene manipulation experiments, and were approved by the institutional
committees.
DSS-Colitis
For the induction of acute colitis, mice were administered 2% or 4% DSS
(36–50 kDa; MP Biomedicals, Illkirch, France) in their drinking water. The
extent of colitis was monitored daily using the modified method of Cooper
and colleagues (Cooper et al., 1993). Diarrhea was scored daily as follows:
0, normal; 2, loose stools; 4, watery diarrhea. Blood in stool was scored
as follows: 0, normal; 2, slight bleeding; 4, gross bleeding. Weight loss
was scored as follows: 0, none; 1, 1%5%; 2, 5%10%; 3, 10%15%;
4, >15%. Disease activity index was the average of these scores: (combined
score of stool consistency, bleeding and weight loss)/3. Mice were sacrificed
on day 11 or 12.
Cell Preparation
CLP cells were isolated using a previously described method with slight mod-
ifications (Arstila et al., 2000). See Supplemental Experimental Procedures for
details.
Flow Cytometry
Antibodies used in this study are described in Supplemental Experimental Pro-
cedures. All antibodies were used at a 1:100 dilution. A Canto II or FACSCali-
bur flow cytometer (BD Biosciences) and CellQuest software (BD Biosciences)
or FlowJo FACS software were used for the analysis, and a FACS Aria II (BD
Biosciences) was used for cell sorting.
In Vitro Culture and Measurement of Cytokine Concentration
CLP cells (2 3 105) were cultured with or without anti-CD3 (17A2) Ab
(BioLegend, San Diego, USA) for 48 hr at 37C under 5% CO2 in 96-well
flat-bottom plates (Falcon, Becton Dickinson Ltd., Oxford, UK) in a volume
of 0.2 ml RPMI containing 10% FBS. After incubation, the culture supernatant
was collected, and cytokine concentration was measured by ELISA Develop-
ment Kit for mouse TNF-a, IL-6, IL-1b, IL-12p40 (OptiEIA kit, BD PharMingen,
Franklin Lakes, USA), and IL-17, IL-17F, IFN-g, and IL-10 (R&D Systems,
Minneapolis, USA).
Real-Time RT-PCR
Total RNA was extracted with Mammalian Total RNA Miniprep kit (Sigma-
Aldrich、St. Louis, USA). RNA was denatured in the presence of an oligo dT
primer and then reverse transcribed with the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, San Francisco, USA). Quantitative
real-time RT-PCRs were performed with a SYBR Green qPCR kit (Carlsbad,
USA) and an iCycler system (Bio-Rad, Hercules, USA) with the sets of primers
described in Table S2, and the expression of each mRNA was normalized with
gapdh expression level.-Zymosan for 12 hr, and expression of S100a8 was determined by real-time
100A9 (1:1 mixture, 5 mg/ml of each peptide) for 9 hr, and bacterial growth was
e representative of three independent experiments, and data in (B) are repre-
ns ± SD. *p < 0.05, **p < 0.01. See also Figures S5 and S6.
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Figure 6. Dectin-1 Antagonist, Laminarin, Prevents DSS-Colitis in Mice
(A) Peritoneal Mf harvested from 4% thioglycolate broth (TGC)-treated mice were pretreated with 1 mg/ml laminarin for 3 hr and then stimulated with 100 mg/ml
depleted-zymosan for 3 hr. Expression of Il1b and Il6 mRNA was determined by real-time RT-PCR and normalized to Gapdh.
(B and C) DSS-colitis was induced in WTmice after administration of food containing 5% laminarin or curdlan (an agonistic b-glucan) for 3 days. These b-glucans
were kept administered during the experiments, and body weight (B) and colitis disease index (C) were evaluated chronologically (n = 6/group).
(legend continued on next page)
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Figure 7. Lactobacillus Species Closely
Related to L. murinus, which Can Induce
TGF-b and IL-10, Is Present in Human Feces
(A) Ribosomal DNA content of indicated lactoba-
cillus species in mouse and human feces relative to
total 16S rDNA was determined by qPCR (mouse,
n = 4; human, n = 7).
(B) The proportion of indicated bacteria in total
commensal microflora in feces from healthy sub-
jects (n = 18) or IBD patients (n = 30) was deter-
mined by qPCR. Each symbol represents an
individual human sample.
(C) Total cLP cells (1 3 105) from WT mice were
cocultured with 1 3 106 CFU/well of L. murinus,
L. animalis, L.salivarius, L. johnsonii, or L. reuteri for
12 hr. Gene-inducing activity of each lactobacillus
species was determined by qPCR.
Data in (C) are representative of two independent
experiments. Data in (A) and (C) are presented as
means ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.16S rDNA Analysis
See Supplemental Experimental Procedures for details.
Statistical Analysis
Differences in survival rates were evaluated by the log rank test (Mantel-
Cox). Disease activity index and histological score were analyzed using the
Mann-Whitney U test. Differences in parametric data were evaluated by
the Student’s t test. Differences of p < 0.05 were considered statistically
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article at http://
dx.doi.org/10.1016/j.chom.2015.07.003.(D–H) After DSS treatment described in (B) and (C) for 11 days, mice were sacrifice
numbers of total LP cells, neutrophils, and proinflammatory DCs were assessed b
IL-10 in culture supernatants were determined by ELISA (F). The proportion (G) a
(n = 4/group).
(I) L. murinus-specific ribosomal DNA content in feces was determined by real-tim
total bacterial or total lactobacillus rDNA.
Mice used in (A)–(I) are on C57BL/6 background. Data in (A) and (I) are representa
independent experiments. All data are presented as means ± SD. *p < 0.05, **p
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